INSM
Price
$163.46
Change
-$0.26 (-0.16%)
Updated
Jan 14 closing price
Capitalization
34.81B
35 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$23.81
Change
+$0.37 (+1.58%)
Updated
Jan 14 closing price
Capitalization
16.56B
32 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INSM vs ROIV

Header iconINSM vs ROIV Comparison
Open Charts INSM vs ROIVBanner chart's image
Insmed
Price$163.46
Change-$0.26 (-0.16%)
Volume$2.62M
Capitalization34.81B
Roivant Sciences
Price$23.81
Change+$0.37 (+1.58%)
Volume$5.81M
Capitalization16.56B
INSM vs ROIV Comparison Chart in %
View a ticker or compare two or three
VS
INSM vs. ROIV commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a Hold and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (INSM: $163.46 vs. ROIV: $23.81)
Brand notoriety: INSM and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 80% vs. ROIV: 77%
Market capitalization -- INSM: $34.81B vs. ROIV: $16.56B
INSM [@Biotechnology] is valued at $34.81B. ROIV’s [@Biotechnology] market capitalization is $16.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than INSM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 5 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • INSM’s TA Score: 5 bullish, 4 bearish.
  • ROIV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INSM is a better buy in the short-term than ROIV.

Price Growth

INSM (@Biotechnology) experienced а -7.12% price change this week, while ROIV (@Biotechnology) price change was +8.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

INSM is expected to report earnings on Feb 19, 2026.

ROIV is expected to report earnings on Feb 16, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($34.8B) has a higher market cap than ROIV($16.6B). ROIV YTD gains are higher at: 9.723 vs. INSM (-6.079). INSM has higher annual earnings (EBITDA): -1.09B vs. ROIV (-1.14B). ROIV has more cash in the bank: 4.39B vs. INSM (1.68B). ROIV has less debt than INSM: ROIV (98.8M) vs INSM (576M). INSM has higher revenues than ROIV: INSM (447M) vs ROIV (20.3M).
INSMROIVINSM / ROIV
Capitalization34.8B16.6B210%
EBITDA-1.09B-1.14B95%
Gain YTD-6.0799.723-63%
P/E RatioN/A1.97-
Revenue447M20.3M2,202%
Total Cash1.68B4.39B38%
Total Debt576M98.8M583%
FUNDAMENTALS RATINGS
INSM: Fundamental Ratings
INSM
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
14
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
33

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INSMROIV
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
70%
Momentum
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 21 days ago
72%
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 17 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
59%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
INSM
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BKSE119.260.63
+0.53%
BNY Mellon US Small Cap Core Equity ETF
AFGE17.35-0.01
-0.06%
American Financial Group
GMAY41.43-0.05
-0.12%
FT Vest U.S. Eq Mod Buffr ETF - May
IYC106.03-1.15
-1.07%
iShares US Consumer Discretionary ETF
FAI41.39-0.72
-1.70%
First Trust Exchange-Traded Fund II

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
-0.16%
THAR - INSM
74%
Closely correlated
+5.88%
ROIV - INSM
40%
Loosely correlated
+1.58%
AXON - INSM
40%
Loosely correlated
-1.92%
ARRY - INSM
40%
Loosely correlated
-6.70%
XENE - INSM
37%
Loosely correlated
+3.02%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.58%
IMVT - ROIV
61%
Loosely correlated
+4.47%
IDYA - ROIV
47%
Loosely correlated
+5.53%
CRNX - ROIV
47%
Loosely correlated
+2.04%
VIR - ROIV
46%
Loosely correlated
+8.08%
CLDX - ROIV
46%
Loosely correlated
+1.58%
More